Michael Weintraub on Twitter
NEW Data drop at #ADA2023: Retatrutide, a triple agonist (GLP1, GIP, glucagon) lost an incredible 24.2% of their body weight, which amounts to 58 lbs! This data suggests retatrutide is the most effective anti-obesity med to date and approaches bariatric surgery outcomes. pic.twitter.com/rAecoE3d0t— Michael Weintraub (@MWeintraubMD) June 26, 2023
https://twitter.com/MWeintraubMD/status/1673435733497978888
Seonglae Cho
